Entacapone Tablet, Film Coated
Product Images NDC 0527-1830

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Entacapone (NDC 0527-1830). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Lannett Company, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Entacapone 01)

Chemical structure diagram of the active ingredient entacapone, showing its molecular arrangement including functional groups and bonds.*

FDA Label Image

Entacapone Tablets Usp 200 mg 100s Bottle Label (Entacapone 200 mg 100bl)

Label for Entacapone Tablets, USP 200 mg, film-coated oral tablets, supplied in a package of 100. Manufactured by Sunshine Lake Pharma Co., Ltd., China, and distributed by Lannett Company, Inc. The label includes storage instructions, dosing advisory to see package insert, and the product's NDC code 0527-1830.*

FDA Label Image

Entacapone Tablets Usp 200 mg 60s Bottle Label (Entacapone 200 mg 60bl)

Label for Entacapone tablets USP, 200 mg, film-coated oral tablets. The label indicates storage instructions, manufacturer Sunshine Lake Pharma Co., Ltd. in China, and the labeler Lannett Company, Inc. The package contains 60 tablets, with the NDC 0527-1830-35 and includes a barcode on the right side.*

FDA Label Image

Logo0001-01 (Logo0001 01)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.